J B Chemicals & Pharmaceuticals Ltd Financials
Company Logo

J B Chemicals & Pharmaceuticals Ltd Financial Statement

J B Chemicals & Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue914.87
Operating Expense670.36
Net Profit149.80
Net Profit Margin16.37
Earning Per Share9.63
EBIDTA238.73
Effective Tax Rate17.83

J B Chemicals & Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual3,722.92
Operating Expenses Annual2,704.99
Operating Profit Annual1,052.67
Interest Annual9.12
Depreciation166.45
Net Profit Annual652.54
Tax Annual224.56

J B Chemicals & Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning56.37
Cash Flow from Operations884.03
Cash Flow from Investing-289.93
Cash Flow from Financing-574.27
Cash Flow at the End76.21

J B Chemicals & Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)28.28
PBIT Margin (%)23.80
PBT Margin (%)21.19
Net PROFIT Margin (%)17.53
Return On Networth / Equity (%)20.84
Return On Networth /Employed (%)26.54
Return On Assets (%)19.46
Total Debt / Equity (X)0.06
Asset Turnover Ratio (%)1.11

J B Chemicals & Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual1,899.03
Total Current Assets Annual1,778.65
Non Current Assets Annual2,399.24
Total Shareholders Funds Annual3,377.19
Total Assets Annual4,177.90

J B Chemicals & Pharmaceuticals Ltd Earning Calls

EPS (INR)

Expected

9.36

Reported

9.36

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.10%

Jun 2024

EPS beaten by 0.00%

FAQS on J B Chemicals & Pharmaceuticals Ltd Financials

As of Jul 21, 2025, J B Chemicals & Pharmaceuticals Ltd has a market capitalization of 25,253.96 Cr. Value Research classifies it as a Large-Cap company.

Yes, J B Chemicals & Pharmaceuticals Ltd is with a debt-to-equity ratio of 0.00.

In FY 2024 , J B Chemicals & Pharmaceuticals Ltd recorded a total revenue of approximately 3,722.92 Cr marking a significant milestone in the company's financial performance.

J B Chemicals & Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

J B Chemicals & Pharmaceuticals Ltd's current PE ratio is 38.70.

J B Chemicals & Pharmaceuticals Ltd's ROCE averaged 23.0% from the FY ending March 2023 to 2025, with a median of 24.0%. It peaked at 26.1% in March 2025, reflecting strong capital efficiency over the period..

J B Chemicals & Pharmaceuticals Ltd's latest EBIT is Rs. 886.23 Cr, surpassing the average EBIT of Rs. 742.15 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions